This report shares Icon’s efforts through 2023 as leading providers across cancer care, pharmacy, research and compounding. Delivering more than three million patient interactions across Australia, New Zealand, Singapore, Mainland China, and beyond, together we are making strides in the fight against cancer and providing hope to more people, families and communities.
Through 2023, we opened new cancer centres, introduced leading technologies and treatment techniques, increased our clinical trials capacity, and announced industry partnerships to further turn the dial on cancer care globally.
